Literature DB >> 22126969

Structure of cyclic nucleoside phosphonate ester prodrugs: an inquiry.

Ivan S Krylov1, Valeria M Zakharova, Michaela Serpi, Ralf Haiges, Boris A Kashemirov, Charles E McKenna.   

Abstract

The configuration at phosphorus in <span class="Chemical">cyclic (S)-HPMPC (1, cidofovir) and (S)-HPMPA (2) phenyl ester (5 and 6, respectively) diastereomers ((R(p))-5, (R(p))-6, (S(p))-6) was determined by X-ray crystallography and correlated to their (1)H and (31)P NMR spectra in solution. (R(p))-5 and (R(p))-6 have chair conformations with the nucleobase substituent equatorial and the P-OPh axial. Perhaps surprisingly, (S(p))-6 is (a, a) in the crystal and exists largely as an equilibrium of (a, a)/(e, e) conformers in chloroform or acetonitrile.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126969      PMCID: PMC3254244          DOI: 10.1021/jo201735f

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  20 in total

1.  Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies.

Authors:  Valeria M Zakharova; Michaela Serpi; Ivan S Krylov; Larryn W Peterson; Julie M Breitenbach; Katherine Z Borysko; John C Drach; Mindy Collins; John M Hilfinger; Boris A Kashemirov; Charles E McKenna
Journal:  J Med Chem       Date:  2011-08-03       Impact factor: 7.446

Review 2.  Highlights in the discovery of antiviral drugs: a personal retrospective.

Authors:  Erik De Clercq
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

3.  Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.

Authors:  Larryn W Peterson; Jae-Seung Kim; Paul Kijek; Stefanie Mitchell; John Hilfinger; Julie Breitenbach; Kathy Borysko; John C Drach; Boris A Kashemirov; Charles E McKenna
Journal:  Bioorg Med Chem Lett       Date:  2011-05-03       Impact factor: 2.823

4.  Comparison of the antiviral activities of alkoxyalkyl and alkyl esters of cidofovir against human and murine cytomegalovirus replication in vitro.

Authors:  William B Wan; James R Beadle; Caroll Hartline; Earl R Kern; Stephanie L Ciesla; Nadejda Valiaeva; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents.

Authors:  Marcela Krecmerová; Antoín Holý; Graciela Andrei; Karel Pomeisl; Tomás Tichý; Petra Brehová; Milena Masojídková; Martin Dracínský; Radek Pohl; Genevieve Laflamme; Lieve Naesens; Hon Hui; Tomas Cihlar; Johan Neyts; Erik De Clercq; Jan Balzarini; Robert Snoeck
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

6.  On the existence of the chair conformation in six-membered ring phosphates bearing an aryl group axially oriented at the C4 position: cyclic nucleotides as model compounds for cyclic phosph(on)ate and phosphoramide prodrugs.

Authors:  Leticia Quintero; Mario Sánchez-Vazquez; Silvano Cruz-Gregorio; Fernando Sartillo-Piscil
Journal:  J Org Chem       Date:  2010-09-03       Impact factor: 4.354

7.  Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro.

Authors:  James R Beadle; Caroll Hartline; Kathy A Aldern; Natalie Rodriguez; Emma Harden; Earl R Kern; Karl Y Hostetler
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity.

Authors:  Marcela Krecmerová; Antonín Holý; Radek Pohl; Milena Masojídková; Graciela Andrei; Lieve Naesens; Johan Neyts; Jan Balzarini; Erik De Clercq; Robert Snoeck
Journal:  J Med Chem       Date:  2007-10-19       Impact factor: 7.446

9.  Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig.

Authors:  Ajay M Tammewar; Lingyun Cheng; Karl Y Hostetler; Iryna Falkenstein; James R Beadle; Erin C Barron; Igor Kozak; William R Freeman
Journal:  J Ocul Pharmacol Ther       Date:  2007-10       Impact factor: 2.671

10.  Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.

Authors:  E De Clercq; T Sakuma; M Baba; R Pauwels; J Balzarini; I Rosenberg; A Holý
Journal:  Antiviral Res       Date:  1987-12       Impact factor: 5.970

View more
  1 in total

1.  Evolution of an amino acid based prodrug approach: stay tuned.

Authors:  Ivan S Krylov; Boris A Kashemirov; John M Hilfinger; Charles E McKenna
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.